Keith Robinson

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Patient Reported

Mild Cognitive Impairment

Peritoneal Dialysis

Top Venues

Journal of clinical pharmacology

Science translational medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Arastoo, Michael P Mazanetz, Sonya Miller, Helen Shiells, Claire Hull, Keith Robinson, John M D Storey, Charles R Harrington, Claude M Wischik
Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants. International journal of molecular sciences 24 (18) (2023)
Aaron M Gusdon, Nauder Faraday, John S Aita, Sunil Kumar, Ishan Mehta, HuiMahn A Choi, Jeffery L Cleland, Keith Robinson, Louise D McCullough, Derek K Ng, Rangaramanujam M Kannan, Sujatha Kannan
Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial. Science translational medicine 14 (654) (2022)
Keith Robinson
Conflation of Tuskegee Study with FDA Fiduciary Responsibilities Sensationally Ignores International Law. Journal of clinical pharmacology (2021)